Chimin(SH:603222)2023-10-30 16:00Financial Performance - The company's operating revenue for Q3 2023 was ¥233,284,270.18, representing a year-on-year increase of 15.10%[4] - The net profit attributable to shareholders for Q3 2023 was ¥5,843,567.20, a decrease of 65.24% compared to the same period last year[4] - The basic earnings per share for Q3 2023 was ¥0.01, down 66.67% year-on-year[5] - Total operating revenue for the first three quarters of 2023 reached ¥677,627,000.76, an increase of 5.8% compared to ¥639,857,724.52 in the same period of 2022[19] - Net profit for the first three quarters of 2023 was ¥61,349,444.39, a decrease of 15.1% from ¥72,240,344.21 in the same period of 2022[20] - Earnings per share for the first three quarters of 2023 were ¥0.08, down from ¥0.17 in the same period of 2022[21] Assets and Liabilities - The total assets at the end of the reporting period were ¥2,623,130,867.65, a decrease of 3.35% from the end of the previous year[5] - As of September 30, 2023, the total assets of the company amounted to ¥2,623,130,867.65, a decrease from ¥2,714,060,425.59 at the end of 2022[15] - The company's current assets totaled ¥874,628,876.54, down from ¥1,046,444,861.54 in the previous year[16] - The total liabilities as of the end of the third quarter of 2023 amounted to ¥852,222,661.97, a decrease from ¥939,637,779.38 at the end of 2022[18] - The total equity attributable to shareholders of the parent company was ¥1,687,162,206.11, slightly down from ¥1,706,949,742.99 in the previous year[18] Cash Flow - The cash flow from operating activities for the year-to-date was ¥86,587,048.29, down 40.79% year-on-year[9] - Cash flow from operating activities for the first three quarters of 2023 was ¥674,785,941.93, a decrease from ¥688,457,444.78 in 2022[23] - The net cash flow from operating activities for Q3 2023 was ¥86,587,048.29, a decrease of 40.9% compared to ¥146,225,545.18 in Q3 2022[24] - The company received tax refunds amounting to ¥9,881,451.22, compared to ¥51,573,137.85 in the previous year[24] - Cash outflow for operating activities was ¥635,938,551.84, slightly lower than ¥641,578,746.19 in Q3 2022[24] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 28,382[10] - The largest shareholder, Shuangge Group Co., Ltd., held 127,983,520 shares, accounting for 23.82% of the total shares[11] - The top ten shareholders include significant holdings such as 127,983,520 shares by Shuangge Group Co., Ltd.[12] - The company repurchased a total of 5,964,800 shares, representing 1.11% of the total share capital[13] Research and Development - Research and development expenses for the first three quarters of 2023 were ¥21,841,589.34, a decrease of 10.4% compared to ¥24,253,211.54 in 2022[19] Sales and Expenses - The company experienced a significant drop in export sales of safety syringes, impacting overall profitability[8] - Total operating costs for the first three quarters of 2023 were ¥619,320,318.07, up from ¥568,254,927.50 in 2022, reflecting an increase of 9.0%[19] - The company experienced a decrease in sales expenses, which were ¥120,506,164.88 in 2023 compared to ¥116,494,704.54 in 2022, reflecting a rise of 3.0%[19] Investment Activities - Total cash inflow from investment activities was ¥384,577,618.36, significantly higher than ¥30,945,318.20 in the previous year[24] - The net cash flow from investment activities was -¥193,887,935.85, worsening from -¥117,923,223.20 year-over-year[24] Financing Activities - Cash inflow from financing activities totaled ¥213,422,400.00, down from ¥550,334,267.90 in the same quarter last year[25] - The net cash flow from financing activities was -¥210,550,216.29, compared to -¥89,299,062.59 in Q3 2022[25] - The company reported a total cash outflow of ¥423,972,616.29 from financing activities, compared to ¥639,633,330.49 in Q3 2022[25]